Comprehensive Analysis of D-Allulose Production: A Review and Update

If you buy D-allulose or formulate with it, production economics matter. A 2024 review in the journal Foods (DOI: 10.3390/foods13162572) takes a close look at how D-allulose is made. The picture is clear: enzymatic conversion has moved to the center of the production map.

Why this review matters

D-allulose has become a serious option for food producers. Regulatory changes made that possible. In 2019, the U.S. FDA determined that allulose is GRAS. China’s NHC approved allulose as a new food ingredient. Those decisions opened wider use across beverages, dairy, bakery, and confectionery.

But approval is not enough. You need reliable supply and workable cost. The review focuses on exactly that. It updates the field on D-allulose production, with an emphasis on enzyme-based methods.

The production landscape

The paper covers recent work in four areas: enzyme immobilization, discovery of new enzymes, directed evolution, and metabolic pathway modification for biosynthesis. Each of these attacks a different production problem.

Immobilization helps you reuse enzymes. New enzyme discovery gives you catalysts with better properties. Directed evolution improves those catalysts further. Pathway engineering lets whole cells do the heavy lifting.

The authors reviewed the progress across all four areas. Their central message is practical. Enzyme technology is the main route to better D-allulose production.

What the study did

The researchers looked at advances in D-allulose production technology, specifically enzymatic conversion. They reviewed methods that convert D-fructose into D-allulose.

One process stands out. A multi-enzyme cascade system achieved a 75% conversion rate from D-fructose to D-allulose in fruit juice systems. The total yield was 60%. Those numbers matter.

A high conversion rate means less fructose left behind. A good yield means less product lost during processing. Together, they point to a more efficient production path.

The table below summarizes the production routes highlighted in the review.

Production route	Main emphasis
Enzyme immobilization	Reuse and stability of enzymes
New enzyme discovery	Better biocatalysts for the conversion step
Directed evolution	Engineered enzymes with improved performance
Metabolic pathway modification	Whole-cell biosynthesis approaches

What it means for manufacturers

The regulatory window is open. GRAS status in the U.S. and NHC approval in China make allulose a practical ingredient, not a niche one. But production volume has to catch up with interest. The review points to enzymes as the bottleneck and the solution.

Ask your supplier about their process. Do they use immobilized enzymes? Are their enzymes engineered? Do they run a single-enzyme system or a cascade? The answers show up in price and supply reliability.

The multi-enzyme cascade result is a benchmark. If a supplier can hit 75% conversion and 60% yield, they have a real advantage. You want that efficiency in your supply chain. Better conversion lowers raw material needs. Better yield lowers purification costs. Those savings travel down the chain.

For formulators, this review is a useful reference. It tells you what to ask for. It also tells you what is realistic.

FAQ

Q: Is allulose approved for use in China? A: Yes. China’s NHC approved allulose as a new food ingredient. That makes the Chinese market more accessible for allulose-containing products.

Q: How efficient is the multi-enzyme cascade method? A: The reviewed process achieved a 75% conversion rate from D-fructose to D-allulose, with a total yield of 60%.

Q: What production methods did the review cover? A: The review covered enzyme immobilization, new enzyme discovery, directed evolution, and metabolic pathway modification.

The production side of allulose is where the ingredient wins or loses. The 2024 review gives buyers and formulators a clear benchmark. Ask for conversion rates. Look at yields. Then decide who deserves your business.